Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Precipio Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS
Ticker
Exchange
SIC #
Website
Latest Ticker
PRPO
Nasdaq
3826
http://www.precipiodx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Precipio Inc
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
- Feb 13th, 2024 3:00 pm
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
- Feb 6th, 2024 3:00 pm
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter
- Jan 23rd, 2024 3:00 pm
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
- Jan 17th, 2024 3:30 pm
Precipio Announces Christina Valauri joins the Board of Directors
- Jan 2nd, 2024 2:00 pm
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024
- Dec 14th, 2023 9:30 pm
Precipio Announces Q3-2023 Shareholder Update Call
- Nov 16th, 2023 10:00 pm
When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven?
- Nov 16th, 2023 10:07 am
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022
- Oct 18th, 2023 1:00 pm
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023
- Oct 3rd, 2023 2:00 pm
Precipio Continues to Sign New HemeScreen™ Customers
- Sep 28th, 2023 1:00 pm
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven
- Sep 25th, 2023 3:00 pm
Precipio Takes Final Step Towards Regaining Nasdaq Compliance
- Sep 21st, 2023 1:00 pm
Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan
- Sep 13th, 2023 1:30 pm
11 ChatGPT Penny Stock Picks
- Aug 31st, 2023 7:26 pm
Broker Revenue Forecasts For Precipio, Inc. (NASDAQ:PRPO) Are Surging Higher
- Aug 20th, 2023 12:02 pm
Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript
- Aug 19th, 2023 10:01 am
Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story
- Aug 13th, 2023 2:16 pm
Precipio Announces Q2-2023 Shareholder Update Call
- Aug 10th, 2023 9:00 pm
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel
- Aug 8th, 2023 1:00 pm
Scroll